Header Logo

Connection

WARREN C FISKUS to Administration, Oral

Back to Details
This is a "connection" page, showing publications WARREN C FISKUS has written about Administration, Oral.
WARREN C FISKUS
Connection Strength
0.020
Administration, Oral
  1. Phase II trial of panobinostat, an oral pan-deacetylase inhibitor in patients with primary myelofibrosis, post-essential thrombocythaemia, and post-polycythaemia vera myelofibrosis. Br J Haematol. 2013 Aug; 162(3):326-35.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.